Literature DB >> 34545332

Corrigendum to "miR-183-5p Is a Potential Molecular Marker of Systemic Lupus Erythematosus".

Shaolan Zhou1,2, Jing Zhang1,3,4, Pengfei Luan1,3, Zhanbing Ma1,3, Jie Dang1,3, Hong Zhu2, Qian Ma1,3, Yanfeng Wang1,3, Zhenghao Huo1,3,5.   

Abstract

[This corrects the article DOI: 10.1155/2021/5547635.].
Copyright © 2021 Shaolan Zhou et al.

Entities:  

Year:  2021        PMID: 34545332      PMCID: PMC8449717          DOI: 10.1155/2021/9818203

Source DB:  PubMed          Journal:  J Immunol Res        ISSN: 2314-7156            Impact factor:   4.818


In the article titled “miR-183-5p Is a Potential Molecular Marker of Systemic Lupus Erythematosus” [1], Figure 8 was formatted incorrectly. The authors have corrected this error and provided the correct figure as follows:
Figure 1

miR-183-5p directly targets Foxo1 3′UTR. (a) The binding site of miR-183-5p and the position 226-242 of Foxo1 3′UTR wild type (WT) and mutant type (mut). (b) miR-183-5p ectopic expression significantly inhibited luciferase activity of the wild-type Foxo1 3′UTR reporter plasmid in comparison with the mutated counterpart. Groups labelled with different letters are statistically different from each other (∗p < 0.05). Differences between groups were analyzed for statistical significance by ANOVA with Fischer's probable least-square difference post hoc test.

  1 in total

1.  miR-183-5p Is a Potential Molecular Marker of Systemic Lupus Erythematosus.

Authors:  Shaolan Zhou; Jing Zhang; Pengfei Luan; Zhanbing Ma; Jie Dang; Hong Zhu; Qian Ma; Yanfeng Wang; Zhenghao Huo
Journal:  J Immunol Res       Date:  2021-05-06       Impact factor: 4.818

  1 in total
  1 in total

1.  Curcumin Elevates microRNA-183-5p via Cathepsin B-Mediated Phosphatidylinositol 3-Kinase/AKT Pathway to Strengthen Lipopolysaccharide-Stimulated Immune Function of Sepsis Mice.

Authors:  Yanan Liu; LiZhi Feng; Guo Hou; Lan Yao
Journal:  Contrast Media Mol Imaging       Date:  2022-07-30       Impact factor: 3.009

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.